Title : Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment.

Pub. Date : 2013 Nov 15

PMID : 24095090






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment. KRCA-0008 anaplastic lymphoma kinase Mus musculus
2 KRCA-0008 is selective and potent to ALK and Ack1, and displays drug-like properties without hERG liability. KRCA-0008 anaplastic lymphoma kinase Mus musculus